Literature DB >> 35708153

Indigenous Nigeria medicinal herbal remedies: A potential source for therapeutic against rheumatoid arthritis.

Uche O Arunsi1,2, Ogbuka E Chioma3, Paschal E Etusim4, Solomon E Owumi5.   

Abstract

Rheumatoid arthritis (RA) is a debilitating disease associated with locomotion impairment, and conventional therapeutic drugs are not optimal for managing RA. There is an avalanche of medications used for the management of RA. Still, studies have shown that they are associated with severe side effects, including hepatotoxicity, retinopathy, and cardiotoxicity disorders of the central nervous system (CNS), skin, blood, and infections. Complementary and alternative medicine (CAM) is currently gaining attention as a novel panacea for managing debilitating diseases, such as RA. Nigerian folk herbal remedies are replete with a plethora of curative medicine, albeit unvalidated scientifically but with seemingly miraculous provenance. Studies of the identification of bioactive compounds present in these botanicals using advanced spectral analytical techniques have enhanced our understanding of the role of Nigerian herbal remedies in the treatment and management of RA. Interestingly, experimental studies abound that the bioactive compounds present in the extracts of plant botanicals protected animals from the development of RA in different experimental models and reduced the toxicity associated with conventional therapeutics. Validated mechanisms of RA amelioration in human and animal models include suppression of the expression of NF-κB, IL-1β, TNF-α, IL-6, IL-8, IL-17, IL-23, chemokines, TGF-β, RANKL, RANK, iNOS, arginase, COX-2, VEGFA, VEGFR, NFATC1, and TRAP in the synoviocytes. Decreased ROS, NO, MDA, carbonyl groups, and PGE2 in the synovial fluid increased the expression of PPARα/γ; antioxidant and anti-inflammatory molecules also improve RA etiology. In this mini-review, we discuss the global burden of RA, the novel role of plant-based botanicals as potential therapeutics against signaling pathways in RA. Also addressed is the possible repurposing/reprofiling of plant botanicals to increase their therapeutic index among RA patients that patronize traditional healers in Nigeria with a global projection.

Entities:  

Keywords:  Rheumatoid arthritis; alternative medicine; bioactive compounds; ethnomedicine; medicinal plants; reprofiling

Mesh:

Substances:

Year:  2022        PMID: 35708153      PMCID: PMC9335509          DOI: 10.1177/15353702221102901

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  262 in total

1.  The roles of synovial hyperplasia, angiogenesis and osteoclastogenesis in the protective effect of apigenin on collagen-induced arthritis.

Authors:  Yunxia Li; Biao Yang; Jia-Yu Bai; Shuyue Xia; Mingqing Mao; Xiaoyang Li; Nan Li; Lei Chen
Journal:  Int Immunopharmacol       Date:  2019-05-24       Impact factor: 4.932

2.  T helper cell subpopulations repertoire in peripheral blood and its correlation with sex of newly diagnosed arthritis patients: A gender based study.

Authors:  Somaiya Mateen; Haris Saeed; Shagufta Moin; Abdul Qayyum Khan; Mohammad Owais
Journal:  Int Immunopharmacol       Date:  2019-06-06       Impact factor: 4.932

3.  NIK-IKK complex interaction controls NF-κB-dependent inflammatory activation of endothelium in response to LTβR ligation.

Authors:  Paulina Kucharzewska; Chrissta X Maracle; Kim C M Jeucken; Jan Piet van Hamburg; Elisabeth Israelsson; Mark Furber; Sander W Tas; Henric K Olsson
Journal:  J Cell Sci       Date:  2019-04-03       Impact factor: 5.285

4.  A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis.

Authors:  Gerd R Burmester; Iain B McInnes; Joel Kremer; Pedro Miranda; Mariusz Korkosz; Jiri Vencovsky; Andrea Rubbert-Roth; Eduardo Mysler; Matthew A Sleeman; Alex Godwood; Dominic Sinibaldi; Xiang Guo; Wendy I White; Bing Wang; Chi-Yuan Wu; Patricia C Ryan; David Close; Michael E Weinblatt
Journal:  Ann Rheum Dis       Date:  2017-02-17       Impact factor: 19.103

5.  ACPA (anti-citrullinated protein antibodies) and rheumatoid arthritis.

Authors:  Rene E Toes; Diane van der Woude
Journal:  Acta Reumatol Port       Date:  2011 Jul-Sep       Impact factor: 1.290

Review 6.  Transforming growth factor β activated kinase 1: a potential therapeutic target for rheumatic diseases.

Authors:  Sabrina Fechtner; David A Fox; Salahuddin Ahmed
Journal:  Rheumatology (Oxford)       Date:  2017-07-01       Impact factor: 7.580

7.  Absence of rheumatoid arthritis in a rural Nigerian population.

Authors:  A J Silman; W Ollier; S Holligan; F Birrell; A Adebajo; M C Asuzu; W Thomson; L Pepper
Journal:  J Rheumatol       Date:  1993-04       Impact factor: 4.666

Review 8.  The rheumatoid arthritis HLA-DRB1 shared epitope.

Authors:  Joseph Holoshitz
Journal:  Curr Opin Rheumatol       Date:  2010-05       Impact factor: 5.006

Review 9.  The central role of T cells in rheumatoid arthritis.

Authors:  A P Cope; H Schulze-Koops; M Aringer
Journal:  Clin Exp Rheumatol       Date:  2007 Sep-Oct       Impact factor: 4.473

10.  Therapeutic Effects of a TANK-Binding Kinase 1 Inhibitor in Germinal Center-Driven Collagen-Induced Arthritis.

Authors:  Cynthia Louis; Devi Ngo; Damian B D'Silva; Jacinta Hansen; Louisa Phillipson; Helene Jousset; Patrizia Novello; David Segal; Kate E Lawlor; Christopher J Burns; Ian P Wicks
Journal:  Arthritis Rheumatol       Date:  2018-11-26       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.